GCV Asia Congress 2017
Skip Content

10 November 2010

23andMe adds $22m

Google-backed 23andMe gains Johnson & Johnson Development Corporation as a new investor.

Author: James Mawson, Editor-in-chief

US-based personal genetics research company 23andMe has raised $22m in its series C round from a consortium including new investor Johnson & Johnson Development Corporation (JJDC), the corporate venturing unit of a local healthcare company.